Table 1.

Clinical and biochemical characteristics of participants with type 1 diabetes

	Normo	Micro	Macro	P
n	34	21	13
Age, years	47±16	48±17	48±12	0.9
Male, %	54	62	56
Diabetes duration, years	20±11	24±13	27±6	0.14
BMI	28±5	27±4	28±7	0.72
Systolic blood pressure mm Hg	129±20	135±16	140±19	0.17
Fasting glucose, mmol/1	10.0±4.4	9.5±2.7	9.4±3.8	0.89
HbA1c, %	7.8±0.8	8.2±1.0	9.3±1.8«	0.001
AER, μg/min	6.1 ×/÷2.7	43.2×/÷1.6	827.8×/÷2.5
iGFR, ml/min/1.73 m2	81±11	89±24	84±23	0.34
Total cholesterol, mmol/1	4.6±0.9	4.4±1.2	4.4±1.2	0.80
LDL-cholesterol, mmol/1	2.8±0.8	2.9±1.5	2.9±1.2	0.90
HDL-cholesterol, mmol/1	1.4±0.7	1.5±0.6	1.4±0.5	0.90
Triglycérides, mmol/1	0.8±0.4	1.2±0.8	1.4±0.8∗	0.01
Medication use, %
ACE inhibitors	17	61	50	0.013
ARBs	13	33	25	0.29
β-Blockers	13	17	38	0.29
Diuretics	13	6	38	0.09
Statins	34	52	36	0.39

Data are means 8 SD except for AER, which is shown as the geometric mean ×/÷ tolerance factor and medication use, which is displayed as % use. ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HbA_1c = glycated hemoglobin; iGFR = isotopic GFR.

^∗p < 0.001 vs. Normo.